Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particles

1 Sept 1994

Abstract excerpt

The L1 major capsid protein-coding sequences of human papillomavirus (HPV) types 11, 16 and 18 were expressed in the baculovirus system. Virus-like particles (VLPs) were purified from recombinant-infected Spodoptera frugiperda Sf9 cells and cell-free culture supernatants. Rabbits immunized with purified VLPs developed antibodies that reacted only with the specific VLP type used as the immunogen. In addition,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Virus Infections Studies
Share to Cervical Cancer and HPV Research
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 8077946
DOI: 10.1099/0022-1317-75-9-2445

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serological differentiation of human papillomavirus types 11, 16 and 18 using recombinant virus-like particlesPMID 8077946Read ↗

Production of recombinant virus-like particles from human papillomavirus types 6 and 11, and study of serological reactivities between HPV 6, 11, 16 and 45 by ELISA: implications for papillomavirus prevention and detection.Semantic proximity Read ↗

NHPV16 VLP Vaccine Induces Human Antibodies That Neutralize Divergent Variants of HPV16Semantic proximity Read ↗

Identification of a Human Papillomavirus Type 16-Specific Epitope on the C-Terminal Arm of the Major Capsid Protein L1Semantic proximity Read ↗

The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.Semantic proximity Read ↗

A Virus-Like Particle Enzyme-Linked Immunosorbent Assay Detects Serum Antibodies in a Majority of Women Infected With Human Papillomavirus Type 16Semantic proximity Read ↗

Chimeric Human Papillomavirus Type 16 (HPV-16) L1 Particles Presenting the Common Neutralizing Epitope for the L2 Minor Capsid Protein of HPV-6 and HPV-16Semantic proximity Read ↗

Sequence and antigenic diversity in two immunodominant regions of the L2 protein of human papillomavirus types 6 and 16.Semantic proximity Read ↗

HPV11 mutant virus-like particles elicit immune responses that neutralize virus and delineate a novel neutralizing domain.Semantic proximity Read ↗

Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancerSemantic proximity Read ↗

Characterization of a Major Neutralizing Epitope on Human Papillomavirus Type 16 L1Semantic proximity Read ↗

Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies.Semantic proximity Read ↗

Production of immunogenic recombinant L1 protein of bovine papillomavirus type 9 causing teat papillomatosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.